On the other hand, in different studies examining neuregulin-4 in metabolic syndrome and non-alcoholic fatty liver disease, it has been shown that there is a negative correlation between neuregulin-4, fasting glucose and TG and a positive correlation with HDL cholesterol [22,46,47]. Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.